The study demonstrated that TNBC was closely related to BRCA1 mutations, compared to patients with BRCA2 mutations carriers or non-carriers, breast cancer patients with BRCA1 mutation are more likely to have TNBC [33]. The gene discussed is BRCA2; the disease is breast carcinoma.